Literature DB >> 9711173

[Fatal course of measles infection in a patient with a low-grade malignant non-Hodgkin lymphoma].

A Klimkiewicz1, M Müller-Schulz, C Gerigk, U Neumann, P Ostendorf.   

Abstract

HISTORY AND CLINICAL
FINDINGS: A 35-year-old man, for 6 years known to have non-Hodgkin lymphoma (NHL) was admitted because of deteriorating general condition, drowsiness and 11 days of flu-like symptoms. A generalized rash had been noted 5 days after onset of symptoms. His 2-year-old son had fallen ill with measles a few days earlier. The patient had reportedly had measles as a child. On admission a generalized rash was found, he had a fever of 40.5 degrees C, tachypnoea, conjunctivitis and possible meningismus. INVESTIGATIONS: Lactate dehydrogenase activity was raised to 458 U/ml, and C-reactive protein to 240 mg/ml. Cerebrospinal fluid contained 8/3 cells and protein of 269 mg/l. The chest radiogram revealed opacification in the left upper lobe. Computed tomography of the skull demonstrated a pansinusitis. DIAGNOSIS, TREATMENT AND COURSE: As measles encephalitis seemed unlikely he was treated for the measles superinfection of bacterial pneumonitis (measles RNA in the bronchoalveolar lavage) and the sinusitis with broad-spectrum antibiotics. After initial improvement artificial ventilation had to be be gun on day 3 because of an acute respiratory distress syndrome, diagnosed both clinically and radiologically. Despite additional antiviral and intensive medical treatment he died on day 11.
CONCLUSION: Patients with impaired immunocompetence due to NHL may lose their immunological "memory" for a previous measles infection. Prevention of exposure may therefore be necessary, in addition to early hyperimmunoglobulin administration.

Entities:  

Mesh:

Year:  1998        PMID: 9711173     DOI: 10.1055/s-2007-1024096

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Screening extracts of Zanthoxylum chalybeum and Warburgia ugandensis for activity against measles virus (Swartz and Edmonston strains) in vitro.

Authors:  D Olila; J Opuda-Asibo
Journal:  Afr Health Sci       Date:  2002-04       Impact factor: 0.927

2.  Fatal measles pneumonitis during Hodgkin's lymphoma.

Authors:  Benjamin Wyplosz; Marion Lafarge; Lélia Escaut; Jean-Baptiste Stern
Journal:  BMJ Case Rep       Date:  2013-10-08

3.  Measles Outbreak in Pediatric Hematology and Oncology Patients in Shanghai, 2015.

Authors:  Yan-Ling Ge; Xiao-Wen Zhai; Yan-Feng Zhu; Xiang-Shi Wang; Ai-Mei Xia; Yue-Fang Li; Mei Zeng
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.